These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4320342)

  • 21. [Composition of nutrient media and toxin formation of Clostridium perfringens].
    Urguev KR
    Veterinariia; 1974 Mar; 3(0):46-7. PubMed ID: 4365136
    [No Abstract]   [Full Text] [Related]  

  • 22. Lecithinase-negative variants of Clostridium perfringens; the identity of C. plagarum with C. perfringens.
    Nakamura S; Sakurai M; Nishida S
    Can J Microbiol; 1976 Oct; 22(10):1497-501. PubMed ID: 184898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Patterns in the development of deep cultures of Cl. perfringens].
    Akhundova KA; Nenashev VP; Artemenko VD
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Dec; 47(12):29-34. PubMed ID: 4324430
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fibrinolytic activity of the toxins of Cl. perfringens, Cl. oedematiens and Cl. septicum in mono- and mixed gas infection].
    Zhak SP; Mitskevich AI; Shtefan EE
    Mikrobiol Zh; 1969; 31(3):271-2. PubMed ID: 4311958
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pathogenicity of various toxinogenic types of Clostridium perfringens administered by mouth to axenic and holoxenic mice].
    Hudault S; Bridonneau C; Raibaud P
    Ann Microbiol (Paris); 1983; 134B(2):277-83. PubMed ID: 6316828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Conditions of formation of anatoxins of Clostridium perfringens, Cl. Oedematiens and Cl. septicum from toxins obtained in casein media].
    Nechaevskaia MR; Cherkas GP; Kalinichenko NF; Berezhkovskaia LIa; Biriukova SV; Podgornaia LG; Mukhina AA; Polchenko OT; Leĭbova IM; Konik VIa
    Mikrobiol Zh; 1966; 28(4):56-61. PubMed ID: 4297878
    [No Abstract]   [Full Text] [Related]  

  • 27. Growth conditions of clostridium perfringens type B for production of toxins used to obtain veterinary vaccines.
    Viana Brandi I; Domenici Mozzer O; Jorge EV; Vieira Passos FJ; Lopes Passos FM; Cangussu AS; Macedo Sobrinho E
    Bioprocess Biosyst Eng; 2014 Sep; 37(9):1737-42. PubMed ID: 24573216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The characteristics of glycerophosphatase of Clostridium perfringens].
    Kachelkina AI; Blagoveshchenskiĭ VA
    Dokl Akad Nauk SSSR; 1966 Dec; 171(5):1193-5. PubMed ID: 4298094
    [No Abstract]   [Full Text] [Related]  

  • 29. [Toxins and anatoxins of Clostridium perfringens].
    Cherkas GP; Kalinichenko MF; Biriukova SV; Podgornaia LG
    Mikrobiol Zh; 1971; 33(2):173-5. PubMed ID: 4326475
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of zinc in the production of Clostridium perfringens alpha toxin.
    Sato H; Murata R
    Infect Immun; 1973 Sep; 8(3):360-9. PubMed ID: 4354149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The enteric toxins of Clostridium perfringens.
    Smedley JG; Fisher DJ; Sayeed S; Chakrabarti G; McClane BA
    Rev Physiol Biochem Pharmacol; 2004; 152():183-204. PubMed ID: 15517462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A study of the arginine desimidase system in toxigenic and weak-toxigenic strains of Clostridium perfringens type A].
    Blagoveshchenskiĭ VA; Dolgikh MS; Borishpolets ZI
    Dokl Akad Nauk SSSR; 1969; 188(2):458-61. PubMed ID: 4315663
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on the dermotoxins of the 6 Clostridium welchii types in rabbits].
    Matthes S
    Zentralbl Bakteriol Orig; 1965 Jul; 196(4):508-15. PubMed ID: 4287430
    [No Abstract]   [Full Text] [Related]  

  • 34. [De novo synthesis of lecithinase by Clostridium perfringens].
    Shemanova GF; Shakhanina KL; Malkina LA
    Dokl Akad Nauk SSSR; 1967 Apr; 173(5):1203-5. PubMed ID: 4315702
    [No Abstract]   [Full Text] [Related]  

  • 35. Selective determination of hemolytic activity of alpha or theta toxin of Clostridium perfringens.
    Akama K; Yamamoto A; Kameyama S
    Jpn J Med Sci Biol; 1969 Aug; 22(4):273-7. PubMed ID: 4311585
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cell wall fine structure of Clostridium perfringens, Cl. septicum and Cl. novyi].
    Schallehn G; Wecke J
    Zentralbl Bakteriol Orig A; 1974; 228(1):63-71. PubMed ID: 4154684
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of antibiotics on the formation of toxin of Cl. perfringens type A].
    Vlasenko AP; Larina IA; Pavlova IB
    Antibiotiki; 1970 Sep; 15(9):790-3. PubMed ID: 4321365
    [No Abstract]   [Full Text] [Related]  

  • 38. [Simple method for constantly obtaining a high-titer perfringens alpha-toxin. I. Role of the medium for toxigenesis and of dextrin].
    Stavri D; Bittner J; Ficiu S
    Arch Roum Pathol Exp Microbiol; 1964 Dec; 23(4):1025-36. PubMed ID: 4284523
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dynamics of phosphorus compounds in the development of C1. perfringens].
    Maiorova IP; Blagoveshchenskii VA; Volkova ZM; Orlova NG
    Biokhimiia; 1965; 30(4):675-80. PubMed ID: 4286712
    [No Abstract]   [Full Text] [Related]  

  • 40. [Observations of potentiation of toxins of Clostridium perfringens and Clostridium histolyticum].
    Mitskevich AI
    Mikrobiol Zh; 1967; 29(2):125-9. PubMed ID: 4308692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.